Emcure Pharma stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5 as the company ...

The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...

Emcure signs exclusive agreement with Sanofi India to distribute and promote its oral anti-diabetic brands Amaryl and Cetapin ...

Mumbai: Emcure Pharmaceuticals Ltd. and Sanofi India Limited have entered into an exclusive distribution and promotion ...

Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...

Emcure Pharmaceuticals Limited announced the appointment of Mr. R.S. Vasan as President - India Business and Senior ...

Emcure Pharmaceuticals partners with Sanofi India to distribute and promote oral anti-diabetic products in India.

Pune: Emcure Pharma has announced the appointment of R.S. Vasan as President - India Business and Senior Management Personnel ...

Emcure Pharmaceuticals and Sanofi India have entered in a partnership to distribute and promote Sanofi’s oral anti-diabetic ...

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Pharma giants like Cipla, Glenmark, and Emcure are stepping into the booming skincare market, challenging beauty brands with ...

KPRDO acknowledges Emcure’s positive response on exclusive stockist appointment for special category sales: Nandita ...